Press release
Rising Thyroid Cancer Cases, Particularly In Women, Propel Market Growth: A Key Driver Powering Thyroid Cancer Drugs Market Growth In 2025
Thyroid Cancer Drugs
_x000D_
What Is the Current Thyroid Cancer Drugs Market Size and Its Estimated Growth Rate?_x000D_
The thyroid cancer drugs market has grown rapidly in recent years. It will grow from $1.17 billion in 2024 to $1.35 billion in 2025, at a compound annual growth rate (CAGR) of 15.5%. This growth is attributed to the increasing incidence of thyroid cancer, advancements in medical research, a favorable regulatory environment, and higher healthcare expenditure._x000D_
_x000D_
The thyroid cancer drugs market is projected to expand rapidly, reaching $2.2 billion by 2029 with a CAGR of 13.0%. Growth is supported by aging demographics, precision medicine developments, improved healthcare facilities, and early screening efforts. Trends include customized treatments, targeted and immune therapies, drug development pipelines, therapy combinations, biomarker-based treatments, and remote care options._x000D_
_x000D_
Purchase the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2601_x000D_
_x000D_
How Are Emerging Segments Shaping the Thyroid Cancer Drugs Market Landscape?_x000D_
The thyroid cancer drugs market covered in this report is segmented -_x000D_
_x000D_
1) By Drug Type: Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Other Drug Types_x000D_
2) By Type: Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Other Types_x000D_
3) By End Users: Hospitals, Oncology Clinics, Research Organizations, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Ipilimumab: Monotherapy Ipilimumab, Combination Therapy With Ipilimumab_x000D_
2) By Cabozantinib-S-Malate: Single-Agent Cabozantinib, Combination Therapy With Cabozantinib_x000D_
3) By Caprelsa (Vandetanib): Vandetanib For Medullary Thyroid Cancer (MTC), Combination Therapy With Vandetanib_x000D_
4) By Doxorubicin Hydrochloride: Doxorubicin For Chemotherapy, Liposomal Doxorubicin_x000D_
5) By Lenvatinib Mesylate: Lenvatinib For Differentiated Thyroid Cancer (DTC), Combination Therapy With Lenvatinib_x000D_
6) By Nivolumab: Monotherapy Nivolumab, Combination Therapy With Nivolumab_x000D_
7) By Vandetanib: Single-Agent Vandetanib, Combination Therapy With Vandetanib_x000D_
8) By Other Drug Types: Sorafenib, Everolimus, Pembrolizumab_x000D_
_x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=2601&type=smp_x000D_
_x000D_
Which Growth Factors Are Influencing Thyroid Cancer Drugs Market Expansion?_x000D_
The increasing number of thyroid cancer cases, particularly among women, is fueling the growth of the thyroid cancer drugs market. For example, The American Cancer Society reported that in 2022, the United States had around 43,800 new thyroid cancer cases-31,940 in women and 11,860 in men-with 2,230 total deaths, including 1,160 women and 1,070 men. This trend in rising cancer incidence is boosting the market's growth._x000D_
_x000D_
Who Are the Dominant Players Across Different Thyroid Cancer Drugs Market Segments?_x000D_
Major companies operating in the thyroid cancer drugs market include Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Baxter International Inc., Abbott Laboratories, APP Pharmaceuticals LLC, AstraZeneca PLC, GlaxoSmithKline plc, Exelixis Inc., Novartis AG, Pfizer Inc., Biovista Inc., Vascular Biogenics Ltd., Azaya Therapeutics Inc., Bionomics Limited, Bayer AG, Eisai Co. Ltd., Bio-Path Holdings Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Bristol-Myers Squibb Company, Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company), Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Hikma Pharmaceuticals PLC, Ipsen Biopharmaceuticals Inc., Johnson & Johnson, Kyowa Kirin Co. Ltd., Merck & Co. Inc., Sanofi S.A., Amgen Inc., Astellas Pharma Inc., Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Gilead Sciences Inc., Grifols S.A., Jazz Pharmaceuticals plc, Mallinckrodt Pharmaceuticals (a subsidiary of Specialty Generics Holdings), Medtronic plc, Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co. Ltd._x000D_
_x000D_
What Thyroid Cancer Drugs Market Trends Are Gaining Traction Across Different Segments?_x000D_
Combination drugs are increasingly used in the treatment of thyroid cancer due to their effectiveness in preventing cancer progression. These drugs combine two or more active pharmaceutical ingredients (APIs) into a single dosage form, helping reduce drug resistance and tumor growth. For example, the FDA approved the combination of dabrafenib (Tafinlar) and trametinib (Mekinist) for treating anaplastic thyroid cancer._x000D_
_x000D_
Get the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report_x000D_
_x000D_
Which Geographic Regions Are Expected to Dominate the Thyroid Cancer Drugs Market in the Coming Years?_x000D_
North America was the largest region in the thyroid cancer drugs market in 20232. Middle East is expected to be the fastest-growing region in the thyroid cancer drugs market during the forecast period. The regions covered in the thyroid cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
Frequently Asked Questions:_x000D_
1. What Is the Market Size and Growth Rate of the Thyroid Cancer Drugs Market?_x000D_
2. What is the CAGR expected in the Thyroid Cancer Drugs Market?_x000D_
3. What Are the Key Innovations Transforming the Thyroid Cancer Drugs Industry?_x000D_
4. Which Region Is Leading the Thyroid Cancer Drugs Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Thyroid Cancer Cases, Particularly In Women, Propel Market Growth: A Key Driver Powering Thyroid Cancer Drugs Market Growth In 2025 here
News-ID: 4056540 • Views: …
More Releases from The Business Research Company
Increasing Demand For Personal Care And Cosmetic Products Drives Coconut Oil Mar …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Coconut Oil Market Size By 2025?
In the last few years, the coconut oil market has experienced substantial growth. The market size is projected to rise from $5.03 billion in 2024 to $5.49 billion in 2025, which is an annual compound growth rate (CAGR) of 9.2%. This growth in the…
Driving Cloud Security Market Growth in 2025: The Role of Countering The Surge I …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Security Market Size Growth Forecast: What to Expect by 2025?
The size of the cloud security market has notably increased over the past few years. The market is projected to expand from a value of $17.11 billion in 2024 to reach $19.71 billion in 2025, representing a compound annual growth rate (CAGR) of…
Comprehensive Cloud Based Contact Center Market Forecast 2025-2034: Growth Trend …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Based Contact Center Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion in the cloud based contact center market has been substantial in the past few years. Its market size is projected to rise from $26.36 billion in 2024 to $31.04 billion in 2025, escalating at a compound…
Explosive Growth In The Consumer Electronics Fuels Circuit Protection Market: Po …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Circuit Protection Market Through 2025?
In recent times, the circuit protection market has experienced significant expansion. The market, which was valued at $54.5 billion in 2024, is projected to rise to $59.88 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. Factors contributing to…
More Releases for Thyroid
Thyroid Cancer Treatment Market Increasing Ageing Population and Thyroid Cancer …
The thyroid cancer treatment market is projected to grow with a moderate CAGR during the forecast period, i.e., 2021-2029 on account of the increasing healthcare expenditure and the rising prevalence of thyroid cancer. As per The American Society of Clinical Oncology, in 2020, 44,280 number of adults in the United States is estimated to suffer from thyroid cancer. Such increasing prevalence of thyroid cancer is further expected to drive the…
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
The number of patients suffering from thyroid gland disorders across the globe is increasing at a rapid rate. This direct increase in demand is expected to be a primary driver for the development of thyroid gland disorder treatments. The number of patients with thyroid gland disorder is increasing due to a growing population of the elderly, who are prone to thyroid disorders and similar illnesses.
Additionally, a person suffering from…
